Brilinta vs Leqvio
A side-by-side look at two cardiovascular medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Brilinta | US Leqvio |
|---|---|---|
| Generic name | ticagrelor Unverified catalogue summary (Generic name) for Brilinta in US; not checked against current local product information. | inclisiran Unverified catalogue summary (Generic name) for Leqvio in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Brilinta in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Leqvio in US; not checked against current local product information. |
| Treats | Acute coronary syndrome, heart attack prevention Unverified catalogue summary (Treats) for Brilinta in US; not checked against current local product information. | High cholesterol Unverified catalogue summary (Treats) for Leqvio in US; not checked against current local product information. |
| Category | Cardiovascular Unverified catalogue summary (Category) for Brilinta in US; not checked against current local product information. | Cardiovascular Unverified catalogue summary (Category) for Leqvio in US; not checked against current local product information. |
| Manufacturer | AstraZeneca Pharmaceuticals LP (US distributor) Unverified catalogue summary (Manufacturer) for Brilinta in US; not checked against current local product information. | Novartis Unverified catalogue summary (Manufacturer) for Leqvio in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Brilinta in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Leqvio in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Brilinta in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Leqvio in US; not checked against current local product information. |
| Est. TV ad spend | $120M | $90M |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Brilinta in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Leqvio in US; not checked against current local product information. |
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Brilinta or Leqvio better?
This directory does not compare clinical effectiveness or safety. Listing Brilinta and Leqvio together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Brilinta and Leqvio?
The table shows catalogue identification and estimated advertising information for Brilinta and Leqvio, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Brilinta has the larger estimated TV advertising budget of the two.